LXRX
LXRX clinical trials: LEXICON PHARMACEUTICALS, INC.
Every trial on ClinicalTrials.gov where LEXICON PHARMACEUTICALS, INC. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 69
- Trials linked
- 61
- As lead sponsor
- 8
- As collaborator
- 1
- Primary completions as lead sponsor, next 90 days
LXRX on the catalyst calendar · LXRX registry changes
- Primary completion Jan 2027Sponsor estimatePhase 3NCT06481891A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic CardiomyopathyLexicon Pharmaceuticals · Obstructive Cardiomyopathy, HypertrophicActive, not recruitingLXRXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 18, 2022ActualPhase 2NCT04662281Efficacy and Safety of LX9211 in Participants With Postherpetic NeuralgiaLexicon Pharmaceuticals · Postherpetic NeuralgiaCompletedLXRXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 14, 2025ActualPhase 2NCT06203002A Dose-ranging Study in Patients With Diabetic Peripheral Neuropathic Pain (DPNP)Lexicon Pharmaceuticals · Diabetic Peripheral Neuropathic PainCompletedLXRXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 23, 2022ActualPhase 2NCT04455633Efficacy, Safety, and PK of LX9211 in Participants With Diabetic Peripheral Neuropathic PainLexicon Pharmaceuticals · Diabetic Peripheral NeuropathyCompletedLXRXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 5, 2020ActualPhase 3NCT03521934Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)Lexicon Pharmaceuticals · Heart FailureTerminatedLXRXLeadSNYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 8, 2020ActualPhase 3NCT03315143Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at...Lexicon Pharmaceuticals · Heart FailureTerminatedLXRXLeadSNYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 22, 2019ActualPhase 3NCT03386344Efficacy and Bone Safety of Sotagliflozin 400 and 200 mg Versus Placebo in Participants With Type 2 Diabetes Mellitus Who Have...Lexicon Pharmaceuticals · Type 2 Diabetes MellitusTerminatedLXRXLeadSNYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 25, 2019ActualPhase 3NCT03242252Safety and Efficacy Study of Sotagliflozin on Glucose Control in Participants With Type 2 Diabetes, Moderate Impairment of Kidney...Lexicon Pharmaceuticals · Type 2 Diabetes MellitusCompletedLXRXLeadSNYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 16, 2019ActualPhase 3NCT03242018A Study to Evaluate Safety and Effects of Sotagliflozin 400 and 200 mg on Glucose Control in Participants With Type 2 Diabetes, Severe...Lexicon Pharmaceuticals · Type 2 Diabetes MellitusCompletedLXRXLeadSNYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 22, 2019ActualPhase 3NCT02926937Efficacy and Safety of Sotagliflozin Versus Placebo in Patients With Type 2 Diabetes Mellitus Not Currently Treated With Antidiabetic...Lexicon Pharmaceuticals · Type 2 Diabetes MellitusCompletedLXRXLeadSNYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 16, 2019ActualPhase 3NCT03351478Efficacy and Safety of Sotagliflozin Versus Placebo and Empagliflozin in Participants With Type 2 Diabetes Mellitus Who Have Inadequate...Lexicon Pharmaceuticals · Type 2 Diabetes MellitusCompletedLXRXLeadSNYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 6, 2019ActualPhase 3NCT03332771Efficacy and Safety of Sotagliflozin Versus Glimepiride and Placebo in Participants With Type 2 Diabetes Mellitus That Are Taking...Lexicon Pharmaceuticals · Type 2 Diabetes MellitusCompletedLXRXLeadSNYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 17, 2019ActualPhase 2NCT03292653Safety, Tolerability and Pharmacodynamic Activity of Sotagliflozin in Hemodynamically Stable Participants With Worsening Heart FailureLexicon Pharmaceuticals · Cardiac Failure AggravatedTerminatedLXRXLeadSNYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 17, 2019ActualPhase 3NCT03285594Efficacy and Safety of Sotagliflozin Versus Placebo in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control...Lexicon Pharmaceuticals · Type 2 Diabetes MellitusCompletedLXRXLeadSNYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 17, 2019ActualPhase 3NCT03066830Efficacy and Safety of Sotagliflozin Versus Placebo in Participants With Type 2 Diabetes Mellitus on Background of Sulfonylurea Alone or...Lexicon Pharmaceuticals · Type 2 Diabetes MellitusCompletedLXRXLeadSNYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 26, 2019ActualPhase 3NCT02926950Efficacy and Safety of Sotagliflozin Versus Placebo in Patients With Type 2 Diabetes Mellitus on Background of MetforminLexicon Pharmaceuticals · Type 2 Diabetes MellitusCompletedLXRXLeadSNYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 2017ActualPhase 3NCT02531035A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With...Lexicon Pharmaceuticals · Type 1 Diabetes Mellitus (T1DM)CompletedLXRXLeadSNYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 2016ActualPhase 2NCT02459899Dose-ranging Study in Patients With Type 1 Diabetes MellitusLexicon Pharmaceuticals · Type 1 Diabetes MellitusCompletedLXRXLeadSNYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 2016ActualPhase 3NCT02421510Efficacy, Safety, and Tolerability Study of Sotagliflozin as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have...Lexicon Pharmaceuticals · Type 1 Diabetes MellitusCompletedLXRXLeadSNYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 2016ActualPhase 3NCT02384941Efficacy, Safety, and Tolerability Study of Sotagliflozin as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have...Lexicon Pharmaceuticals · Type 1 Diabetes MellitusCompletedLXRXLeadSNYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 2016ActualPhase 2NCT02383940Efficacy and Safety of Sotagliflozin in Young Adult Patients With Type 1 Diabetes Mellitus and Elevated Hemoglobin A1CLexicon Pharmaceuticals · Type 1 Diabetes MellitusCompletedLXRXLeadSNYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 2014ActualPhase 2NCT01742208Safety and Efficacy of Sotagliflozin (LX4211) in Patients With Inadequately Controlled Type 1 Diabetes MellitusLexicon Pharmaceuticals · Type 1 Diabetes MellitusCompletedLXRXLeadSNYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 12, 2018ActualPhase 3NCT02026063Telotristat Etiprate - Expanded Treatment for Patients With Carcinoid Syndrome SymptomsLexicon Pharmaceuticals · Carcinoid SyndromeCompletedLXRXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 3, 2013ActualPhase 2NCT01456052A Study to Evaluate Safety and Efficacy of Telotristat Etiprate (LX1606) in Participants With Acute, Mild to Moderate Ulcerative ColitisLexicon Pharmaceuticals · Ulcerative ColitisCompletedLXRXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 12, 2014ActualPhase 2NCT01104415Study of Telotristat Etiprate (LX1606) in Participants With Symptomatic Carcinoid SyndromeLexicon Pharmaceuticals · Carcinoid SyndromeCompletedLXRXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 25 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScannerShowing the first 25 trials. There are 44 more in this window; the full list is part of TrialScanner.
Unlock with TrialScanner